Gemcitabine
Gemcitabine (LY188011) is a synthetic nucleoside analog that inhibits DNA synthesis, exhibiting antitumor activity by inducing both autophagy and apoptosis. It is widely used in cancer research, including in vitro cell studies and in vivo models for pancreatic, lung, and breast carcinomas.
Product Specifications
CAS Number
95058-81-4
Product Name Alternative
RNA Synthesis, RNASynthesis, Inhibitor, Gemcitabine, inhibit, NSC 613327, NSC613327, NSC-613327, LY188011, LY-188011, LY 188011, Nucleoside Antimetabolite/Analog, NucleosideAntimetabolite, Nucleoside Antimetabolite, Apoptosis, Analog, Autophagy, DNA/RNA Synthesis, DNA synthesis, DNA Synthesis, DNASynthesis
Field of Research
Cell Biology, Molecular Biology, Pharmacology & Drug Discovery
Purity
98.66% (May vary between batches)
Solubility
DMSO:125 mg/mL (474.92 mM) ; Ethanol:12.5 mg/mL (47.49 mM) ; H2O:6.25 mg/mL (23.75 mM) ;5% DMSO+95% Saline:0.75 mg/mL (2.85 mM)
Smiles
NC1=NC (=O) N (C=C1) [C@@H]1O[C@H] (CO) [C@@H] (O) C1 (F) F
Molecular Formula
C9H11F2N3O4
Molecular Weight
263.20
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
